The newest COVID variants circulating widely are known by their Pango lineage names: KP.3.1.1 and XEC. There’s no new Greek letter name like Delta or Omicron because these variants are all still considered part of the Omicron family that has dominated since late 2021. The World Health Organization classifies KP.3.1.1 as a “variant under monitoring,” while XEC gained attention in late 2024 for spreading faster than other strains.
Why There’s No New Greek Letter Name
When COVID variants were dramatically different from one another in 2020 and 2021, the WHO assigned Greek letters: Alpha, Delta, Omicron. Since Omicron took over, every major variant has been a sub-lineage of Omicron rather than something fundamentally new. That means the naming system has shifted to Pango lineage codes, which are strings of letters and numbers like JN.1, KP.3.1.1, and XEC. These names are less catchy, which is partly why people keep searching for “the new COVID.”
KP.3.1.1 and XEC: The Key Variants
KP.3.1.1 was first documented in samples from March 2024 and became one of the dominant strains through late 2024 and into 2025. It’s classified under the Nextstrain clade 24E, a technical grouping that helps scientists track its genetic branch on the overall COVID family tree.
XEC is a recombinant variant, meaning it formed when two different Omicron sub-lineages (KS.1.1 and KP.3.3, both descendants of JN.1) infected the same person at the same time and swapped genetic material. This kind of mixing can occasionally produce a strain with new advantages. In XEC’s case, a mutation in the spike protein’s outer region (adding a sugar molecule to a spot called position 22) changes the shape of the protein enough to help the virus slip past some antibodies. In August 2024, XEC’s reproduction rate was estimated to be about 13% higher than KP.3.1.1’s, giving it a meaningful growth advantage.
How Current Symptoms Compare
The symptom list for the latest variants hasn’t shifted dramatically from what most people experienced with earlier Omicron strains. The CDC’s current list includes fever or chills, cough, sore throat, congestion or runny nose, fatigue, muscle aches, headache, and shortness of breath. Loss of taste or smell, once a hallmark of earlier COVID waves, still appears but is less common. Nausea, vomiting, and diarrhea remain possible but aren’t typical for most people.
Vaccination status and prior infections both influence which symptoms show up and how severe they are. Many people with recent immunity experience something closer to a bad cold that resolves within a week.
Vaccine Protection Against New Variants
The 2024-2025 updated COVID vaccines still offer meaningful protection, though effectiveness is moderate rather than dramatic. CDC data from September 2024 through January 2025 found that vaccination reduced COVID-related emergency department and urgent care visits by 33% among adults 18 and older during the first four months after the shot. For adults 65 and older, protection against hospitalization was stronger: roughly 45-46% among those with healthy immune systems, and about 40% among older adults with weakened immunity.
These numbers reflect the reality that newer variants like XEC have enhanced ability to dodge antibodies. The vaccines still reduce the chance of severe illness, but they don’t block infection as effectively as the original shots did against the original virus.
Do Rapid Tests Still Work?
Home rapid antigen tests still detect current variants, but their sensitivity depends heavily on timing and symptoms. Compared to PCR testing, rapid tests correctly identify about 47% of infections overall. That number jumps to 56% on days when you’re experiencing symptoms and reaches 77% on days when you have a fever. Peak accuracy lands around day 2 to 3 after symptoms start.
The practical takeaway: if you feel sick and test negative, test again in 24 to 48 hours, ideally on a day when symptoms are most noticeable. Testing while asymptomatic catches only about 18% of infections compared to PCR, so a negative result before symptoms appear doesn’t mean much. If you have a fever and test on day 2 or 3 of feeling ill, you can trust the result far more, with sensitivity reaching 80% or higher when compared against viral culture (which measures whether the virus is actually infectious).
What “New COVID” Actually Means Now
COVID’s evolution has settled into a pattern that looks more like flu than the dramatic variant jumps of 2020-2021. New sub-lineages emerge every few months, each with small mutations that give them a slight edge in spreading or evading immunity. XEC’s 13% transmission advantage over KP.3.1.1, for example, is enough to gradually become dominant but not enough to cause a fundamentally different kind of illness. The virus is no longer producing variants different enough to earn new Greek letters, so the “new COVID” is really a continuous series of incremental updates to Omicron, tracked by increasingly complex alphanumeric codes that most people will never need to memorize.